Activity Overview
This educational activity is an archive of the live presentation held on January 8, 2026.
For more information about this educational activity, the faculty, and disclosures, please click here.
Target Audience
This educational activity is directed toward medical oncologists, gastroenterologists, advanced practice providers, nurses, and other health care practitioners involved in the treatment and management of gastrointestinal cancers.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Review the epidemiology, risk factors, pathophysiology, and diagnostic principles essential to early recognition of squamous cell anal carcinoma (SCAC)
- Interpret recent clinical trial data and guideline recommendation updates to inform individualized care planning and optimize therapeutic sequencing in SCAC
- Evaluate the safety and efficacy data of emerging immune checkpoint inhibitors in SCAC
Marwan Fakih, MD
Professor, Medical Oncology and Therapeutics Research
Judy and Bernard Briskin Distinguished Director in Clinical
Research
Associate Director for Clinical Sciences
Medical Director, Briskin Center for Clinical Research
Division Head, GI Medical Oncology
City of Hope Comprehensive Cancer Center
Duarte, CA
Kristen Ciombor, MD, MSCI
Associate Professor of Medicine, Division of Hematology and
Oncology
Vanderbilt University Medical Center
Nashville, TN
Van Karlyle Morris, MD
Associate Professor, GI Medical Oncology
Section Chief, Colorectal Cancer
The University of Texas MD Anderson Cancer Center
Houston, TX
Full faculty information and disclosures are available by reviewing the program workbook, linked here.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
